Cantor Fitzgerald Comments on STOK FY2026 Earnings
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Stoke Therapeutics in a report issued on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos anticipates that the company will post earnings of ($2.51) per share for the year. Cantor Fitzgerald has a […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Stoke Therapeutics in a report issued on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos anticipates that the company will post earnings of ($2.51) per share for the year. Cantor Fitzgerald has a […]
